Loading people...
Joshua Hartz is the Global Head of Special Opportunities and a Partner at Partners Group, splitting his time between Sydney, Australia, and Zug, Switzerland. He brings 20 years of private markets experience to the firm, where he is currently building a dedicated global investment team to execute structured liquidity solutions. Prior to joining Partners Group, Hartz served as a Partner in the Special Situations division at Bain Capital and held senior roles at Anchorage Capital Group and Goldman Sachs. During his tenure at Bain Capital, he led high-profile transactions including the buyout of Virgin Australia and the merger between Accolade Wines and Pernod Ricard Wines. He holds a Bachelor of Arts in Mathematics-Economics and Psychology from Wesleyan University. His current focus centers on leveraging private equity, credit, and royalties capabilities to provide flexible capital to growth businesses.
Joshua Hartz is a highly respected Managing Director at Bain Capital Private Equity, a leading global private investment firm. With a career spanning over a decade at Bain Capital, Hartz has established himself as a pivotal figure in the firm's investment strategies, particularly within the dynamic healthcare sector. His expertise lies in identifying promising companies, structuring complex transactions, and fostering significant growth within portfolio businesses.
As a Managing Director, Joshua Hartz is responsible for sourcing, evaluating, and managing private equity investments. His primary focus is on the healthcare industry, a sector where Bain Capital has a strong track record. Hartz's investment scope includes a wide range of healthcare sub-sectors, such as healthcare services, medical technology, pharmaceuticals, and digital health solutions. He works closely with management teams to implement strategic initiatives, optimize operations, and drive long-term value creation, ultimately aiming to enhance patient care and improve healthcare outcomes.
Joshua Hartz joined Bain Capital in 2005, bringing a robust analytical and strategic background to the firm. Prior to his tenure at Bain Capital, he gained valuable experience in consulting, further honing his business acumen and understanding of diverse industries. Hartz holds an MBA from Harvard Business School and a Bachelor of Arts degree from Dartmouth College, providing him with a strong foundation in finance, economics, and business strategy. His academic achievements, combined with his practical experience, equip him with a comprehensive perspective on market trends and investment opportunities.
Throughout his career at Bain Capital, Joshua Hartz has been involved in numerous significant investments that have shaped the healthcare landscape. While specific deal details are often confidential, his work has consistently focused on companies poised for substantial growth and market leadership. He has played a crucial role in the strategic development and successful exits of various healthcare portfolio companies, contributing to Bain Capital's reputation for generating strong returns. Hartz often serves on the boards of these companies, providing strategic oversight and guidance to ensure their continued success and expansion. His commitment to operational excellence and strategic vision makes him a key asset to Bain Capital's private equity team.
Joshua Hartz is a Managing Director at Bain Capital Private Equity, a prominent global private investment firm. He is known for his expertise in identifying and executing investment opportunities, particularly within the healthcare sector, and for driving strategic growth for portfolio companies.
Joshua Hartz primarily invests in companies within the healthcare sector. His focus areas include healthcare services, medical technology, pharmaceuticals, and digital health solutions, where he seeks to foster innovation and create long-term value.
Joshua Hartz works as a Managing Director at Bain Capital, a leading global private investment firm. He is based in their private equity division, contributing to their extensive portfolio of investments.
